Lower-than-approved doses of GLP-1 medications and isotretinoin (Accutane) are trending on social media. Yale Medicine experts discuss safety, effectiveness, and who may—or may not—be appropriate candidates.
[email protected] (Yale News)
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 10
- Comments 0